98 related articles for article (PubMed ID: 21034717)
1. [Primary cutaneous CD30+ large T-Cell lymphoma with lymph node and cerebral metastases].
Simal E; Hörndler C; Porta N; Baldellou R
Actas Dermosifiliogr; 2010 Nov; 101(9):810-2. PubMed ID: 21034717
[No Abstract] [Full Text] [Related]
2. CD8-positive primary cutaneous anaplastic large cell lymphoma presenting as multiple scrotal nodules and plaques.
Xu H; Qian J; Wei J; Zhao Y; Zhou C; Chen D; Zhang J
Eur J Dermatol; 2011; 21(4):609-10. PubMed ID: 21680287
[No Abstract] [Full Text] [Related]
3. Sustained response of primary cutaneous CD30 positive anaplastic large cell lymphoma to bexarotene and photopheresis.
Sheehy O; Catherwood M; Pettengell R; Morris TC
Leuk Lymphoma; 2009 Aug; 50(8):1389-91. PubMed ID: 19544141
[No Abstract] [Full Text] [Related]
4. Syndrome of inappropriate antidiuretic hormone secretion associated with primary cutaneous anaplastic large cell lymphoma.
Hirata Y; Yokote T; Nishiwaki U; Tsuji M; Hanafusa T
Br J Haematol; 2012 May; 157(4):412. PubMed ID: 22409317
[No Abstract] [Full Text] [Related]
5. Chemotherapy with etoposide, vincristine, doxorubicin, bolus cyclophosphamide, and oral prednisone in patients with refractory cutaneous T-cell lymphoma.
Akpek G; Koh HK; Bogen S; O'Hara C; Foss FM
Cancer; 1999 Oct; 86(7):1368-76. PubMed ID: 10506727
[TBL] [Abstract][Full Text] [Related]
6. Successful treatment for recurrence of primary cutaneous anaplastic large-cell lymphoma in elderly patient with etoposide, mitoxantrone, cyclophosphamide, vincristine, prednisolone and bleomycin (VNCOP-B) therapy.
Isogai R; Fukao M; Kawada A
J Dermatol; 2007 Aug; 34(8):556-60. PubMed ID: 17683387
[TBL] [Abstract][Full Text] [Related]
7. Paraneoplastic cerebellar degeneration: initial presentation in a patient with anaplastic T-cell lymphoma, associated with ichthyosiform cutaneous lesions.
Rodis DG; Liatsos GD; Moulakakis A; Pirounaki M; Tasidou A
Leuk Lymphoma; 2009 Aug; 50(8):1369-71. PubMed ID: 19544138
[No Abstract] [Full Text] [Related]
8. A rare case of ALK negative CD30+ primary cutaneous anaplastic large cell lymphoma in a young adult.
Sridevi HB; Shanthala PR; Raghuveer CV; Prabhu AK; Akbar JK; Shivaprasad GS; Suresh PK; Navani S
J Cancer Res Ther; 2015; 11(3):656. PubMed ID: 26458652
[TBL] [Abstract][Full Text] [Related]
9. Epitrochlear lymph node: an unusual physical finding in lymphoma with important clinical significance.
Goli AK; Koduri M; Goli SA; Byrd RP; Roy TM
Tenn Med; 2006 Sep; 99(9):35-6. PubMed ID: 17225779
[No Abstract] [Full Text] [Related]
10. Four versus six courses of a dose-escalated cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) regimen plus etoposide (megaCHOEP) and autologous stem cell transplantation: early dose intensity is crucial in treating younger patients with poor prognosis aggressive lymphoma.
Schmitz N; Kloess M; Reiser M; Berdel WE; Metzner B; Dorken B; Kneba M; Trumper L; Loeffler M; Pfreundschuh M; Glass B;
Cancer; 2006 Jan; 106(1):136-45. PubMed ID: 16331635
[TBL] [Abstract][Full Text] [Related]
11. Lactic Acidosis in Non-Hodgkin's Lymphoma and response to Chemotherapy.
Osorio S; Bernis C; de La Cámara R
Haematologica; 2002 Feb; 87(2):ELT05. PubMed ID: 11836182
[No Abstract] [Full Text] [Related]
12. Combined treatment with rituximab and anthracycline-containing chemotherapy for primary cutaneous large B-cell lymphomas, leg type, in elderly patients.
Guyot A; Ortonne N; Valeyrie-Allanore L; Bagot M
Arch Dermatol; 2010 Jan; 146(1):89-91. PubMed ID: 20083704
[No Abstract] [Full Text] [Related]
13. Primary cutaneous aggressive epidermotropic CD8+ T-cell lymphoma: report of two cases with no evidence of systemic disease.
Szepesi Á; Csomor J; Rajnai H; Erős N; Wikonkál N; Kárpáti S; Matolcsy A; Marschalkó M
Eur J Dermatol; 2012; 22(5):690-1. PubMed ID: 22940730
[No Abstract] [Full Text] [Related]
14. Treatment of cutaneous B-cell lymphoma, leg type, with age-adapted combinations of chemotherapies and rituximab.
Grange F; Maubec E; Bagot M; Beylot-Barry M; Joly P; Dalle S; Delaporte E; Dereure O; Bachelez H; Vergier B; Petrella T; D'Incan M
Arch Dermatol; 2009 Mar; 145(3):329-30. PubMed ID: 19289772
[No Abstract] [Full Text] [Related]
15. [Primary hepatic non-Hodgkin's lymphoma].
De la Maya MD; Escalante R; Torre A; Urdambidelus C
Sangre (Barc); 1999 Jun; 44(3):242. PubMed ID: 10481592
[No Abstract] [Full Text] [Related]
16. Primary cutaneous anaplastic large-cell lymphoma.
Newlove T; Loyd A; Patel R; Jelinek J; Latkowski JA
Dermatol Online J; 2010 Nov; 16(11):2. PubMed ID: 21163153
[TBL] [Abstract][Full Text] [Related]
17. Management of multifocal primary cutaneous CD30 anaplastic large cell lymphoma.
Shehan JM; Kalaaji AN; Markovic SN; Ahmed I
J Am Acad Dermatol; 2004 Jul; 51(1):103-10. PubMed ID: 15243534
[TBL] [Abstract][Full Text] [Related]
18. [Intestinal lymphoma. A report of 2 cases].
Breda E; Temperilli L
Minerva Med; 1992 Apr; 83(4):223-5. PubMed ID: 1374168
[No Abstract] [Full Text] [Related]
19. Castleman disease and adenocarcinoma.
Megalakaki A; Evmorfiadis I; Stamouli M; Zakopoulou N; Iacovidou I
J BUON; 2011; 16(4):781-2. PubMed ID: 22331742
[No Abstract] [Full Text] [Related]
20. A medical research council randomized trial in patients with primary cerebral non-Hodgkin lymphoma: cerebral radiotherapy with and without cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy.
Mead GM; Bleehen NM; Gregor A; Bullimore J; Shirley D; Rampling RP; Trevor J; Glaser MG; Lantos P; Ironside JW; Moss TH; Brada M; Whaley JB; Stenning SP
Cancer; 2000 Sep; 89(6):1359-70. PubMed ID: 11002232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]